0001127602-12-032064.txt : 20121126 0001127602-12-032064.hdr.sgml : 20121126 20121126182745 ACCESSION NUMBER: 0001127602-12-032064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121121 FILED AS OF DATE: 20121126 DATE AS OF CHANGE: 20121126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAY RUSSELL T CENTRAL INDEX KEY: 0001225960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 121225221 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-11-21 0000850693 ALLERGAN INC AGN 0001225960 RAY RUSSELL T 2525 DUPONT DRIVE IRVINE CA 92612 1 Common Stock 2012-11-21 4 S 0 18000 91.046 D 22800 D Common Stock 2012-11-21 4 M 0 5000 36.85 A 27800 D Common Stock 2012-11-21 4 M 0 5000 45.885 A 32800 D Common Stock 2012-11-21 4 M 0 5000 36.49 A 37800 D Common Stock 2012-11-21 4 S 0 15000 91.0491 D 22800 D Nonemployee Director Stock Option (Right to Buy) 36.85 2012-11-21 4 M 0 5000 0 D 2004-04-25 2013-04-24 Common Stock 5000 0 D Nonemployee Director Stock Option (Right to Buy) 45.885 2012-11-21 4 M 0 5000 0 D 2005-04-28 2014-04-28 Common Stock 5000 0 D Nonemployee Director Stock Option (Right to Buy) 36.49 2012-11-21 4 M 0 5000 0 D 2006-04-26 2015-04-26 Common Stock 5000 0 D The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $90.79 to $91.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote /s/ Matthew J. Maletta, Attorney-in-Fact for Russell T. Ray 2012-11-26